High LYRM4-AS1 predicts poor prognosis and correlates with immune efficacy in patients with glioma

被引：0
|
作者：
Wang, Haiyue [1 ]
Xie, Ying [1 ]
Du, Hongzhen [1 ]
Luo, Bin [1 ]
Li, Zengning [1 ]
机构：
[1] Hebei Med Univ, Hosp 1, Shijiazhuang, Peoples R China
来源：
ANNALS OF NUTRITION AND METABOLISM | 2023年 / 79卷
关键词：
LYRM4; AS1; glioma; prognosis; immune efficacy; bioinformatics analysis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PAB(T4)-96
引用
收藏
页码：690 / 690
页数：1
相关论文
共 50 条
  • [41] High expression of PCOLCE gene indicate poor prognosis in patients and are associated with immune infiltration in glioma
    Guo, Qingbao
    Gao, Xin
    Li, Jingjie
    Liu, Yukun
    Liu, Jiayu
    Yang, Hui
    Cui, Meng
    Zhang, Meng
    Duan, Lian
    Ma, Xiaodong
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [42] Interleukin-1 receptor-associated kinase 4 as a potential biomarker: Overexpression predicts poor prognosis in patients with glioma
    Wang, Jialin
    Liu, Binfeng
    Yao, Jiawei
    Liu, Zhendong
    Wang, Hongbo
    Zhang, Bo
    Lian, Xiaoyu
    Ren, Zhishuai
    Liu, Liyun
    Gao, Yanzheng
    ONCOLOGY LETTERS, 2021, 21 (04)
  • [43] High expression of MACC1 predicts poor prognosis in patients with osteosarcoma
    Zhang, Kai
    Zhang, Yonggang
    Zhu, Huimin
    Xue, Na
    Liu, Jie
    Shan, Chao
    Zhu, Qing
    TUMOR BIOLOGY, 2014, 35 (02) : 1343 - 1350
  • [44] High RBMS1 Predicts Poor Prognosis in Patients with Diabetes Mellitus
    Yan, Yong-xin
    Wang, Guo-feng
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2022, 36 (04): : 1035 - 1042
  • [45] High GLI-1 expression predicts poor prognosis in AML patients
    El Zaiat, Reham
    Abd Momen, Khaled
    El Feshawy, Alia
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 60 - 60
  • [46] Decapping enzyme 2 is a novel immune-related biomarker that predicts poor prognosis in glioma
    Mei, Yuran
    Lv, Qiaoli
    Tan, Zilong
    Zhang, Zhe
    Ji, Yulong
    Chen, Shuhui
    Shen, Xiaoli
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2024, 40 (04) : 4262 - 4283
  • [47] MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma
    Sun, Jin-Zhang
    Zhang, Jin-Hao
    Li, Jia-Bo
    Yuan, Feng
    Tong, Lu-Qing
    Wang, Xu-Ya
    Chen, Lu-Lu
    Fan, Xiao-Guang
    Zhang, Yi-Ming
    Ren, Xiao
    Zhang, Chen
    Yu, Sheng-Ping
    Yang, Xue-Jun
    DISEASE MARKERS, 2021, 2021
  • [48] Analysis and Validation of TMED3 correlates with poor prognosis and tumor immune infiltration of glioma
    Gang Liao
    Meimei Zhang
    Chunliang Wang
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 3485 - 3494
  • [49] Analysis and Validation of TMED3 correlates with poor prognosis and tumor immune infiltration of glioma
    Liao, Gang
    Zhang, Meimei
    Wang, Chunliang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3485 - 3494
  • [50] High expression of monocarboxylate transporter 4 predicts poor prognosis in patients with lung adenocarcinoma
    Ruan, Yushu
    Zeng, Fanjun
    Cheng, Zhiqiang
    Zhao, Xianda
    Fu, Pin
    Chen, Honglei
    ONCOLOGY LETTERS, 2017, 14 (05) : 5727 - 5734
12345